Interview with the CEO of Synthetic Biologics, Jeff Riley

February 8, 2016- Interviewed by Steven E. Greer, MD

We spoke with Jeff Riley, the CEO of Synthetic Biologics, about the importance of the microbiome to our intestinal health.

This entry was posted in - Biotech, Gastroenterology and liver, Infectious disease, NIH. Bookmark the permalink.

One Response to Interview with the CEO of Synthetic Biologics, Jeff Riley

  1. Betty Becker says:

    I have had IBS-C for umpteenth years. I am interested in SYN-OIO and when it
    would be available to doctors for patients.

Leave a Reply

Your email address will not be published. Required fields are marked *